Reports for SANOFI-AVENTIS CANADA INC
Company Name SANOFI-AVENTIS CANADA INC |
||
|---|---|---|
Totals |
||
Shortage reports |
281 |
|
| Actual shortage: | 5 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 16 (6%) | |
| Resolved: | 260 (93%) | |
Discontinuation Reports |
58 |
|
| To be discontinued: | 7 (12%) | |
| Discontinued: | 51 (88%) | |
| Reversed: | 0 (0%) | |
Late reports |
22 (6%) |
|
Overdue reports |
9 (75%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-10-31 | 2023-07-12 | 173205 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-10-18 | 2023-07-12 | 172103 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-09-27 | 2022-10-12 | 170358 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-08-26 | 2022-09-14 | 168019 |
| APIDRA | 100UNIT | SOLUTION | Avoided shortage | 2019-11-26 | 2019-11-26 | 99685 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-10-07 | 2023-07-12 | 171433 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2019-11-26 | 2020-01-28 | 99690 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2021-05-06 | 2021-05-12 | 138831 |
| ARAVA | 10MG | TABLET | Resolved | 2023-07-19 | 2023-11-28 | 199224 |
| ARAVA | 10MG | TABLET | Resolved | 2022-08-02 | 2023-01-27 | 165914 |
| ARAVA | 20MG | TABLET | Resolved | 2023-02-15 | 2023-06-14 | 184712 |
| ARAVA 10MG | 10MG | TABLET | Resolved | 2019-11-29 | 2020-04-25 | 100069 |
| ARAVA 20 MG | 20MG | TABLET | Resolved | 2020-11-16 | 2020-12-02 | 128414 |
| ARAVA 20 MG | 20MG | TABLET | Resolved | 2019-11-29 | 2020-04-25 | 100066 |
| AUBAGIO | 14MG | TABLET | Resolved | 2022-04-25 | 2022-05-04 | 159348 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2022-08-11 | 2022-08-11 | 166530 |
| AVALIDE | 12.5MG 300MG | TABLET | Avoided shortage | 2022-04-14 | 2022-08-11 | 158890 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-07-16 | 2020-01-24 | 89482 |
| AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2018-12-20 | 2019-02-27 | 70230 |
| AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2019-10-09 | 2020-01-24 | 95800 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RENVELA | 2.4G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239436 |
| RENVELA | 0.8G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239433 |
| RENVELA | 800MG | TABLET | To be discontinued | 2025-03-31 | 2025-03-31 | 253680 |
| RIFADIN | 300MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134218 |
| RIFADIN | 150MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134215 |
| RIFATER | 300MG 120MG 50MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3688 |
| SECTRAL | 200MG | TABLET | Discontinued | 2018-07-09 | 2018-09-07 | 54767 |
| SECTRAL | 400MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3692 |
| SECTRAL | 100MG | TABLET | Discontinued | 2018-09-17 | 2018-10-03 | 61609 |
| TALWIN | 50MG | TABLET | Discontinued | 2020-11-09 | 2021-02-06 | 128146 |
| TALWIN | 50MG | TABLET | Discontinued | 2021-02-09 | 2021-02-09 | 133620 |
| TAXOTERE | 80MG | SOLUTION | To be discontinued | 2018-06-27 | 2018-10-17 | 53064 |
| TAXOTERE | 20MG | SOLUTION | Discontinued | 2018-02-23 | 2018-05-28 | 40870 |
| TUSSIONEX | 5MG 10MG | SUSPENSION | Discontinued | 2019-11-11 | 2020-03-24 | 98368 |
| TUSSIONEX | 5MG 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-08-17 | 2017-08-22 | 19700 |
| ZALTRAP | 200MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121390 |
| ZALTRAP | 100MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121387 |
| ZUACTA | 0.075% | CREAM | Discontinued | 2020-07-30 | 2020-07-30 | 121381 |